CDB-4124* reduces both the duration and intensity of pain associated with endometriosis,

&NA;
In: Inpharma Weekly · 2007 · vol. &NA;(1592) , pp. 6 · doi:10.2165/00128413-200715920-00014 · W4231131953
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite+body, 2026-07-22 ⓘ

This brief report states that EVT 201 is a promising treatment for insomnia, according to Inpharma Weekly.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-02 · read from full text ⓘ

The provided text is a metadata record for an article titled "CDB-4124* reduces both the duration and intensity of pain associated with endometriosis," published in Inpharma Weekly in 2007. The content consists primarily of citation details, DOI links, and access restrictions rather than the full scientific paper or abstract. Consequently, no specific study population, methodology, or detailed clinical findings are available within the supplied text to summarize. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 827 characters · extracted from oa-doi-fallback · click to expand
Rights and permissions About this article Cite this article EVT 201 promising for insomnia. Inpharma Wkly. 1592, 6 (2007). https://doi.org/10.2165/00128413-200715920-00014 Published: Issue date: DOI: https://doi.org/10.2165/00128413-200715920-00014 - Media release - Published: - Volume 1592, page 6 (2007) - Cite this article - 5 Accesses This is a preview of subscription content, log in via an institution to check access. EVT 201 promising for insomnia. Inpharma Wkly. 1592, 6 (2007). https://doi.org/10.2165/00128413-200715920-00014 Published: Issue date: DOI: https://doi.org/10.2165/00128413-200715920-00014 Anyone you share the following link with will be able to read this content: Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-09-28T06:20:55.906821+00:00
License: CC0 · commercial use OK